TY  - GEN
AU  - Siringo, Marco
AU  - Baena, Javier
AU  - Bote de Cabo, Helena
AU  - Torres-Jiménez, Javier
AU  - Zurera, María
AU  - Zugazagoitia, Jon
AU  - Paz Ares, Luis Gonzaga
PY  - 2023
DO  - 10.3390/cancers15235505
SN  - 2072-6694
UR  - https://hdl.handle.net/20.500.12105/23094
AB  - Immune checkpoint inhibitors (ICIs) have revolutionized the management of non-oncogene addicted non-small-cell lung cancer (NSCLC). Blocking the anti-PD-1 axis represents the current standard of care in the first-line setting, with drugs administered...
LA  - eng
PB  - Multidisciplinary Digital Publishing Institute (MDPI)
TI  - Future Perspectives in the Second Line Therapeutic Setting for Non-Oncogene Addicted Non-Small-Cell Lung Cancer.
TY  - research article
ER  -